SLC5A2 and obesity disorder: The glomerular hyperfiltration of severe obesity entails prominent afferent arteriolar vasodilation, and as above, SGLT2 inhibition curbs afferent arteriolar vasodilation through natriuresis and increased tubuloglomerular feedback (72).